I just bought 30000 at $1.705. What's so bad in this? I don't...

I just bought 30000 at $1.705. What's so bad in this? I don't see RED.

Sydney - Tuesday - July 3: (RWE Aust Business News) - Sigma
Pharmaceuticals Ltd (ASX:SIP) has announced that EBITDA for the year to
January 31 is expected to increase by 5 per cent over the previous
corresponding period.
Sigma also confirmed that as part of its ongoing capital
management strategy it will undertake an on-market share buyback of up to
9.9 per cent of its issued ordinary shares.
The share buy-back will commence in about two weeks time
following the normal regulatory notification process.
Due to both higher interest expense and a higher effective tax
rate, Sigma expects profit for the 2007/08 year to be in line with the
previous year, excluding the interest impact associated with the
buy-back.
First-half net profit will be below the prior corresponding
period, but with the skew to the second half of new-product launches and
the impact of Embrace, it is expected that 65 per cent of full-year
underlying net profit for 2007/08 will be generated in the second half.